InspireMD
NSPR
29 hedge funds and large institutions have $29.1M invested in InspireMD in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
12% more funds holding
Funds holding: 26 → 29 (+3)
6.65% more ownership
Funds ownership: 41.33% → 47.98% (+6.6%)
1% more capital invested
Capital invested by funds: $28.7M → $29.1M (+$380K)
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$859K |
| 2 |
O
OrbiMed
New York
|
+$786K |
| 3 |
Millennium Management
New York
|
+$410K |
| 4 |
PVI
Pura Vida Investments
New York
|
+$272K |
| 5 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
+$86.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$716K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$81.1K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$5.13K |
| 4 |
Renaissance Technologies
New York
|
-$4.89K |
NSPR Hedge Fund Activity: Q4 2023 in Review
29 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q4 2023, worth a combined $29.1M — up 1.3% from $28.7M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NSPR positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 1 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $859K. The largest seller was Point72 Asset Management, exiting entirely with an estimated $716K sold.
- 29 institutional investors held InspireMD (NSPR) as of Q4 2023, up from 26 in Q3 2023.
- Funds reported $29.1M of InspireMD stock for Q4 2023, up 1.3% quarter-over-quarter.
- 6 funds opened new InspireMD positions in Q4 2023 and 3 closed out, a net change of +3 holders.
- The largest InspireMD buyer in Q4 2023 was Nantahala Capital Management, an estimated $859K added.
- The largest InspireMD seller in Q4 2023 was Point72 Asset Management, an estimated $716K sold.
Based on aggregated 13F filings for Q4 2023.